The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by which LA1011 may Improve the Prognosis of Alzheimer’s Disease

BIOMOLECULES(2023)

Cited 0|Views17
No score
Abstract
Chaperone systems play a major role in the decline of cognition and contribute to neurological pathologies such as Alzheimer’s disease (AD). While such a decline may occur naturally with age or with stress or trauma, the mechanisms involved have remained elusive. The current models suggest that amyloid-β (Aβ) plaque formation leads to the hyperphosphorylation of tau by a Hsp90 dependent process that triggers tau neurofibrillary tangle formation and neurotoxicity. Several co-chaperones of Hsp90 can influence the phosphorylation of tau, including FKBP51, FKBP52 and PP5. In particular elevated levels of FKBP51 occur with age and stress and are further elevated in AD. Recently, the dihydropyridine, LA1011 was shown to reduce tau pathology and amyloid plaque formation in transgenic AD mice, probably through its interaction with Hsp90 although the precise mode of action is currently unknown. Here, we present a co-crystal structure of LA1011 in complex with a fragment of Hsp90. We show that LA1011 can disrupt binding of FKBP51, which might help to rebalance the Hsp90-FKBP51 chaperone machinery and provide a favourable prognosis towards AD. Clinically, this is highly significant, as AD is generally a disease affecting older patients, where slowing of disease progression could result in AD no longer being life limiting. ### Competing Interest Statement Acknowledgments The owner of the patent application associated with the research compound, LA1011, described herein is Richter Gedeon Plc. pharmaceutical company Patent number 10660789 (https://patents.justia.com/patent/10660789). Conflicts of Interest S.M.R., A.M., J.S., and C.P. declare no conflict of interest. Dr. Tamas Pazmany contributed to the research work presented herein as an employee of Gedeon Richter Plc. T.P., L.V., I.H. and Z.T. declare themselves named on the Richter Gedeon Plc. pharmaceutical company Patent number 10660789 (https://patents.justia.com/patent/10660789).
More
Translated text
Key words
Alzheimer's disease, Hsp90, FKBP51, immunopilin, LA1011, co-chaperone, tau, drug discovery
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined